This is an interesting technology as it uses sound waves to help fight the battle with treating urological cancer. Last year it was announced that he also joined the “think tank” of Newt Gingrich. 
Von Eschenbach Joins Newt Gingrich’s Think Tank – Add a Tiny Bit of Old Knowledge to a Lot of New Methodologies?
I thought some of the values over there we a little off base in a recent commentary. BD
Newt Gingrich Gets Healthcare Value Bass Ackwards–It’s All About Those Algorithms
HistoSonics Inc. brought former Food & Drug Administration commissioner Dr. Andrew von Eschenbach onto its board yesterday.
The ex-commissioner's experience as a surgeon, urological oncologist and healthcare administrator made him a good fit, said the Ann Arbor, Mich.-based company, which is developing a treatment for urological cancer.
CEO Tom Davison said "[Dr. von Eschenbach's] commitment to safe and effective healthcare and especially cancer therapy aligns precisely with HistoSonics’ vision and long term strategy," in a prepared statement.
0 comments :
Post a Comment